Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    gastroenterology

    Alcohol-associated hepatitis

    Also known as: Alcoholic hepatitis, Alcohol-related hepatitis, Alcohol-associated steatohepatitis

    Alcohol-associated hepatitis is an inflammatory condition of the liver caused by alcohol exposure. It typically presents as jaundice and systemic illness, and in severe cases, it can be life-threatening. Clinical assessment, alcohol-use treatment, nutritional support and specialist-directed care are the primary requirements. TCM serves only as an adjunctive framework for symptom support once the patient is clinically stable. The evidence cited here includes an observational association between ACEI/ARB use and improved outcomes in general alcohol-associated liver disease, but this does not prove treatment efficacy for acute hepatitis. Other records describe experimental mechanisms and animal studies rather than established patient benefits. There is no evidence evaluating acupuncture or the formulas listed below for this condition. Traditional pattern selection is never a reason to delay investigation or justify herbal treatment during an active liver injury.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Prioritise absolute alcohol abstinence facilitated by professional addiction services; patients with suspected dependence must undergo medically supervised withdrawal to prevent acute complications.
    • •Adhere to an individualised nutritional plan provided by a dietitian, incorporating frequent, small meals and avoiding fasting or non-clinical 'detoxification' regimens.
    • •Maintain a comprehensive record of all pharmaceuticals, herbal medicines, and supplements; avoid ethanol-based tonics and unverified 'liver-cleansing' products unless medically approved.
    • •Balance adequate rest with gentle physical activity as medically tolerated, and utilise social support for attendance at clinical appointments and assistance with activities of daily living.

    Cautions & Contraindications

    See sources
    • •Defer elective acupuncture during acute deterioration, suspected infection, encephalopathy or haemodynamic instability. Liver and sepsis outcomes in [1] provide context only; it is not an acupuncture safety study.[]
    • •Assess bleeding history, platelet count, coagulation status and antithrombotic medicines before needling; avoid needling with active bleeding or clinically significant bleeding risk pending medical clearance. This precaution is not evaluated in [1].[]
    • •Do not prescribe these formulas or isolated herbal extracts as hepatitis therapy on the basis of animal results. The experimental interventions in [2] and [4] do not establish human dosing, interaction safety or benefit, particularly during active liver injury or pregnancy.[,]
    • •Do not start, stop or switch ACEI/ARB treatment to manage hepatitis on the basis of [1]. Its retrospective association does not establish causation; blood pressure, renal function, potassium and decompensation require prescriber assessment.[]

    When to reassess or seek care again

    See sources

    Suspected acute hepatitis requires same-day medical assessment, not an initial TCM trial. After medical stabilisation and clearance, review adjunctive care within 7–14 days using nausea and fatigue scores, appetite, meal intake, stool pattern and functional capacity. Coordinate clinician-directed bilirubin, INR, creatinine and electrolyte monitoring; weight must be interpreted alongside fluid status. Stop and refer immediately for deterioration, and reconsider adjunctive care if no meaningful symptom benefit after 2–4 sessions.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. Alcohol, clinical & experimental research · 2026
    2. Acta pharmaceutica Sinica. B · 2026
    3. Free radical biology & medicine · 2025
    4. Pharmaceuticals (Basel, Switzerland) · 2026

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.